Poirier Michael S. 4
4 · Qualigen Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Purchase
Common Stock
2022-06-22$0.57/sh+30,000$17,100→ 199,202 total
Holdings
- 11,005(indirect: By IRA)
Common Stock